Page 133 - 《中国药房》2025年14期
P. 133

参考文献                                                    NF-κB/NLRP3 signaling after myocardial infarction[J].
          [ 1 ]  MARTIN  T  P,MACDONALD  E A,ELBASSIONI A A       Int Immunopharmacol,2020,80:106116.
              M,et al. Preclinical models of myocardial infarction:from   [13]  GE Z W,WANG B C,HU J L,et al. IRAK3 gene silen-
              mechanism  to  translation[J].  Br  J  Pharmacol,2022,179  cing  prevents  cardiac  rupture  and  ventricular  remodeling
              (5):770-791.                                        through negative regulation of the NF-κB signaling path‐
          [ 2 ]  CORMICAN D S,SONNY A,CROWLEY J,et al. Acute      way in a mouse model of acute myocardial infarction[J]. J
              myocardial infarction complicated by cardiogenic shock:  Cell Physiol,2019,234(7):11722-11733.
              analysis  of  the  position  statement  from  the  European        [14]  ZHANG  H,YIN  Y,CHEN  S,et  al.  Downregulation  of
              Society  of  Cardiology  Acute  Cardiovascular  Care         RIP3  ameliorates  the  left  ventricular  mechanics  and  fun-
              Association,with perioperative implications[J]. J Cardio‐  ction  after  myocardial  infarction  via  modulating  NF- κB/
              thorac Vasc Anesth,2021,35(10):3098-3104.           NLRP3  pathway[J].  Open  Life  Sci,2024,19(1):
          [ 3 ]  GOLFOROUSH  P,YELLON  D  M,DAVIDSON  S  M.       20220890.
              Mouse  models  of  atherosclerosis  and  their  suitability  for   [15]  JIANG Y,FENG Y P,TANG L X,et al. The protective
              the study of myocardial infarction[J]. Basic Res Cardiol,  role of NR4A3 in acute myocardial infarction by suppres-
              2020,115(6):73.                                     sing inflammatory responses via JAK2-STAT3/NF-κB
          [ 4 ]  SHAN T T,LI  X Y,XIE W  Z,et  al.  Rap1GAP  exacer‐  pathway[J].  Biochem  Biophys  Res  Commun,2019,517
              bates  myocardial  infarction  by  regulating  the  AMPK/  (4):697-702.
              SIRT1/NF-κB signaling pathway[J]. Cell Signal,2024,  [16]  JIN J L,LV R G,GUO J,et al. Improvement of left ven‐
              117:111080.                                         tricular remodelling by inhibition of NF-κB in a rat model
          [ 5 ]  XIE J,LUO C J,MO B H,et al. Inflammation and oxida‐  of  myocardial  infarction[J].  Heart  Lung  Circ,2016,25
              tive stress role of S100A12 as a potential diagnostic and   (10):1007-1012.
              therapeutic  biomarker  in  acute  myocardial  infarction[J].   [17]  FAN D,YANG Z,YUAN Y,et al. Sesamin prevents apop‐
              Oxid Med Cell Longev,2022,2022:2633123.             tosis  and  inflammation  after  experimental  myocardial
          [ 6 ]  MACKMAN  N,BERGMEIER  W,STOUFFER  G A,et         infarction by JNK and NF-κB pathways[J]. Food Funct,
              al. Therapeutic strategies for thrombosis:new targets and   2017,8(8):2875-2885.
              approaches[J].  Nat  Rev  Drug  Discov,2020,19(5):  [18]  CHEN  F,CHEN  Z  Q,ZHONG  G  L,et  al.  Nicorandil
              333-352.                                            inhibits  TLR4/MyD88/NF- κB/NLRP3  signaling  pathway
          [ 7 ]  DOENST T,HAVERICH A,SERRUYS P,et al. PCI and     to reduce pyroptosis in rats with myocardial infarction[J].
              CABG  for  treating  stable  coronary  artery  disease:JACC   Exp Biol Med(Maywood),2021,246(17):1938-1947.
              review topic of the week[J]. J Am Coll Cardiol,2019,73  [19]  LI Z X,YU Z L,CUI S Y,et al. AMPA receptor inhibition
              (8):964-976.                                        alleviates inflammatory response and myocardial apopto‐
          [ 8 ]  WANG Y,CHEN J H,COWAN D B,et al. Non-coding      sis after myocardial infarction by inhibiting TLR4/NF-κB
              RNAs  in  cardiac  regeneration:mechanism  of  action  and   signaling  pathway[J].  Int  Immunopharmacol,2024,133:
              therapeutic potential[J]. Semin Cell Dev Biol,2021,118:  112080.
              150-162.                                       [20]  MA H Z,DU J,FENG X L,et al. Rosiglitazone alleviates
          [ 9 ]  BELIËN H,EVENS L,HENDRIKX M,et al. Combining     myocardial apoptosis in rats with acute myocardial infar-
              stem  cells  in  myocardial  infarction:the  road  to  superior    ction  via  inhibiting  TLR4/NF- κB  signaling  pathway
              repair [J]. Med Res Rev,2022,42(1):343-373.         [J]. Exp Ther Med,2021,22(3):911.
          [10]  ZHANG Q,WANG L,WANG S Q,et al. Signaling path‐  [21]  LI L,WANG Y L,GUO R,et al. Ginsenoside Rg3-loaded,
              ways  and  targeted  therapy  for  myocardial  infarction[J].   reactive  oxygen  species-responsive  polymeric  nanopar‐
              Signal Transduct Target Ther,2022,7(1):78.          ticles  for  alleviating  myocardial  ischemia-reperfusion
          [11]  LIU X D,ZHANG W M,LUO J C,et al. TRIM21 defi‐     injury[J]. J Control Release,2020,317:259-272.
              ciency  protects  against  atrial  inflammation  and  remode-  [22]  TU C C,WAN B Y,ZENG Y. Ginsenoside Rg3 alleviates
              ling  post  myocardial  infarction  by  attenuating  oxidative   inflammation in a rat model of myocardial infarction via
              stress[J]. Redox Biol,2023,62:102679.               the  SIRT1/NF- κB  pathway[J].  Exp  Ther  Med,2020,20
          [12]  LI X,BIAN Y,PANG P,et al. Inhibition of Dectin-1 in   (6):238.
              mice ameliorates cardiac remodeling by suppressing    [23]  SUN J H,WANG R,CHAO T T,et al. Ginsenoside Re in‐


          中国药房  2025年第36卷第14期                                              China Pharmacy  2025 Vol. 36  No. 14    · 1811 ·
   128   129   130   131   132   133   134   135   136   137   138